trending Market Intelligence /marketintelligence/en/news-insights/trending/m6k01c2lw1i1zzm_hdik6a2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

CytRx attracts $7M investment

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Blog

Corporate Credit Risk Trends in Developing Markets: A Probability of Default Perspective


CytRx attracts $7M investment

CytRx Corp. has attracted a $7 million investment from certain institutional investors who will buy 5,600,000 shares of the company at $1.25 each.

CytRx intends to use the money for working capital and general corporate purposes, including possible new drug discovery activities and acquisitions or mergers.

The offering is expected to close by May 15 with H.C. Wainwright & Co. acting as the exclusive placement agent.

The company is developing cancer treatments.